Product Images Pirfenidone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Pirfenidone NDC 51407-914 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407-913-27OL - Pirfenidone 267 mg - Rev. 0624.jpg - 51407 913 27OL Pirfenidone 267 mg Rev. 0624

51407-913-27OL - Pirfenidone 267 mg - Rev. 0624.jpg - 51407 913 27OL   Pirfenidone 267 mg   Rev. 0624

This text contains information about a medication with NDC 51407-913-27. The tablet contains 267 mg of a substance called Pirfenidone. The pharmacist is advised to dispense patient information with each prescription. The medication should be stored between 20° - 25°C (68° - 77°F), with excursions permitted from 15° - 30°C (59° - 86°F). For more patient information, the text provides a link to visit at https://gsms.us/. The medication should be kept out of the reach of children.*

51407-914-90OL - Pirfenidone 801 mg - Rev. 0624.jpg - 51407 914 90OL Pirfenidone 801 mg Rev. 0624

51407-914-90OL - Pirfenidone 801 mg - Rev. 0624.jpg - 51407 914 90OL   Pirfenidone 801 mg   Rev. 0624

Figure1.jpg - Figure1

Figure1.jpg - Figure1

This description provides data on the percentage of patients showing worsening or no decline in Forced Vital Capacity (%FVC) when treated with Pirfenidone compared to a Placebo. The data shows an absolute change in %FVC from baseline to week 52, with 30% and 10% representing the decrease and increase respectively. The study involved 278 participants in the Pirfenidone group and 277 participants in the Placebo group.*

Figure2.jpg - Figure2

Figure2.jpg - Figure2

This text provides information on the mean change in Forced Vital Capacity (FVC) in milliliters (mL) comparing the effects of Pirfenidone with a sample size of 278 to a placebo with a sample size of 277 over various weeks. The data shows a decrease in FVC levels over time in both groups.*

Figure3.jpg - Figure3

Figure3.jpg - Figure3

This text provides statistics on the percentage of patients alive over time when comparing the drug Pirfenidone with a placebo. The data includes the number of patients in each group, hazard ratio (HR) and its 95% Confidence Interval (Cl). The chart shows the percentage of patients alive at different time points and includes the number of patients at risk in each group.*

Structure.jpg - Structure

Structure.jpg - Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.